ST Elevation Myocardial Infarction in the elderly

( views:384, downloads:0 )
Author:
Marcelo Franken(INCOR Heart Institute, University of Sao Paulo Medical School, Av. Dr. Enéas Carvalho de Aguiar, 44-05403-000, S(a)o Paulo, Brasil)
Amit Nussbacher(INCOR Heart Institute, University of Sao Paulo Medical School, Av. Dr. Enéas Carvalho de Aguiar, 44-05403-000, S(a)o Paulo, Brasil)
Alberto Liberman(PUC- Campinas Medical School, Rodovia Dom Pedro I, km 136, Parque das Universidades Campinas (SP), CEP13086-900, Brasil)
Mauricio Wajngarten(INCOR Heart Institute, University of Sao Paulo Medical School, Av. Dr. Enéas Carvalho de Aguiar, 44-05403-000, S(a)o Paulo, Brasil)
Journal Title:
JOURNAL OF GERIATRIC CARDIOLOGY
Issue:
Volume 09, Issue 02, 2012
DOI:
10.3724/SP.J.1263.2011.12297
Key Word:
Myocardial Infarction;Acute coronary syndromes;Elderly people;Management

Abstract: Acute coronary syndromes (ACS) are the leading causes of death in the elderly. The suspicion and diagnosis of ACS in this age group is more difficult, since typical angina is less frequent. The morbidity and mortality is greater in older age patients presenting ACS. Despite the higher prevalence and greater risk, elderly patients are underrepresented in major clinical trials from which evidence based recommendations are formulated. The authors describe, in this article, the challenges in the diagnosis and management of ST elevation myocardial infarction in the elderly, and discuss the available evidence.

  • [1]Vickers LE,Taylor J,Brady AJB.Heart disease in older patients:myocardial infarction.Br J Cardiol 2003;10:123–127.
  • [2]Lee PY,Alexander KP,Hammill BG,et al.Representation of elderly persons and women in published randomized trials of acute coronary syndromes.JAMA 2001;286:708–713.
  • [3]Boucher JM,Racine N,Thanh TH,et al.Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction.CMAJ 2001;164:1285–1290.
  • [4]Halon DA,Adawi S,Dobrecky-Mery I,et al.Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients.J Am Coll Cardiol 2004;43:346–352.
  • [5]Liberman A.Acute coronary syndromes in the elderly–Which is the difference? Rev Soc Cardiol Estado de S(a)o Paulo 2002;4:497–510.
  • [6]Mehta RH,Rathore SS,Radford MJ,et al.Acute myocardial infarction in the elderly:differences by age.J Am Coll Cardiol 2001;38:736–741.
  • [7]Gregoratos G.Clinical manifestations of acute myocardial infarction in older patients.Am J Geriatr Cardiol 2001;10:345–347.
  • [8]Alexander KP,Newby LK,Cannon CP,et al.Acute coronary care in the elderly,Part II.Non-ST-segment-elevation acute coronary syndromes:A scientific statement for healthcare professionals from the American Heart Association Council on clinical cardiology:In collaboration with the Society of Geriatric Cardiology.Circulation 2007;115:2570–2589.
  • [9]Boie ET.Initial evaluation of chest pain.Emerg Med Clin North Am 2005;23:937–957.
  • [10]Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.Indications for fibrinolytic therapy in suspected acute myocardial infarction:collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients.Lancet 1994;343:311–322.
  • [11]Theimam DR,Coresh J,Schulman SP,et al.Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.Circulation 2000,101:2239–2246.
  • [12]Berger AK,Radford MJ,Wang Y,et al.Thrombolytic therapy in older patients.J Am Coll Cardiol 2000;36:366–374.
  • [13]White H.Thrombolytic therapy in the elderly.Lancet 2000;356:2028–2030.
  • [14]Stenestrand U,Wallentin L.Fibrinolytic therapy in patients 75 years and older with ST segment elevation myocardial infarction:one year follow up of a large prospective cohort.Arch Intern Med 2003;163:965–971.
  • [15]Collins R.Optimizing thrombolytic therapy of acute myocardial infarction:Age is not a contraindication.Circulation 1991;84 (Suppl II):II230.
  • [16]Dangas GD,Singh SH.Primary percutaneous coronary intervention in octogenarians:navigate with caution.Heart 2010;96:813–814.
  • [17]Keeley EC,Boura Já,Grines CL.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative review of 23 randomized trials.Lancet 2003;361:13–20.
  • [18]Stone GW,Grines CL,Browne KF,et al.Predictors of inhospital and 6 month outcome after acute myocardial infarction in the repefusion era;the Primary Angioplasty in Myocardial Infarction (PAMI) Trial.J Am Coll Cardiol 1995;25:370–377.
  • [19]A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.The Global Use of Strategies to Open Occluded Coronary Arteries in Acute coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators.N Engl J Med 1997;336:1621–1628.
  • [20]de B(o)er MJ,Ottervanger JP,van't Hof AW,et al.Reperfusion therapy in the elderly patients with acute myocardial infarction:a randomized comparison of primary angioplasty and thrombolytic therapy.J AM Coll Cardiol 2002;39:1723–1728.
  • [21]Mehta RH,Sadiq I,Goldberg RJ,et al.For the GRACE Investigators.Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction.Am Heart J 2004;147:253–259.
  • [22]Degeare VS,Stone GW,Grines CL,et al.Angiografic and clinical characteristics associated with increase in hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials).Am J Cardiol 2000;86:30–34.
  • [23]Nicolau JC,Lemos PA,Wajngarten M,et al.The role of invasive therapies in elderly patients with acute myocardial infarction.Clinics 2009;64:553–560.
  • [24]Piegas LS,Feitosa G,Mattos LA,et al.Brazilian Society of Cardiology.Guidelines from the Brazilian Society of Cardiology about treatment of myocardial infarction with ST-segment elevation.Arq Bras Cardiol 2009;93 (6 Suppl 2):E179–E264.
  • [25]Sabatine MS,Camen CP,Gibson CM,et al.Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST segment elevation.N Eng J Med 2005;352:1179–1189.
  • [26]COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative group.Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction randomized placebo-controlled trial.Lancet 2005;366:1607–1621.
  • [27]Peters RJC,Mehta SP,Fox KAA,et al.Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndrome:observations from the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE study).Circulation 2003;108:1682–1687.
  • [28]Mehta SR,Bassand JP,Chrolavicius S,et al.Dose compareisons of clopidogrel and aspirin in acute coronary syndromes.N Engl J Med 2010;363:930–942.
  • [29]Wiviott SD,Braunwald E,McCabe CH,et al.Prasugrel versus clopidogrel in patients with acute coronary syndromes.N Engl J Med 2007;357:2001–2015.
  • [30]Chin CT,Roe MT,Fox KA,et al.Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction:the targeted platelet inhibition to clarify the optimal strategy to medically manage acute coronary syndromes (TRILOGY ACS) trial.Am Heart J 2010;160:16–22.
  • [31]Wallentin L,Becker RC,Budaj A,et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes.N Engl J Med 2009;361:1045–1057.
  • [32]Husted S,James S,Becker RC,et al.Ticagrelor versus Clopidogrel in elderly patients with acute coronary syndromes:a subanalysis from the prospective randomized platelet inhibition and patient outcomes (PLATO) trial.J Am Coll Cardiol 2011;57:E1099.
  • [33]Gyongyosi M,Domanovits H,Benzer W,et al.Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct related artery and improved myocardial tissue reperfusion:results of the Austrian multicentre randomized ReoPro-BRIDGING study.Eur Heart J 2004;25:2125–2133.
  • [34]Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina:the CAPTURE Study.Lancet 1997;349:1429–1435.
  • [35]Simaeve PR,Alexander GM,Bagart K,et al.Efficacy of tenectplase in combination with enoxaparin abciximab or unfractionated heparin:one year follow up results of the assessment of the safety of a new thrombolytic 3 (ASSENT-3) randomized trial in acute myocardial infarction.AM Heart J 2004;147:993–998.
  • [36]Simmaeve PR,Kerang Y,Begaerts K,et al.Age outcomes and treatment effects of fibrinolytics and antithrombotic combination:findings from assessment of the safety and efficacy of a new thrombolytic (ASSENT-3) and ASSENT -3 PLUS.AM Heart J 2006;152:684–689.
  • [37]De Luca G,Suryapranata M,Stane GW,et al.Abciximab as adjunctive therapy to reperfusion in acute ST segment elevation myocardial infarction:a meta-analysis of randomized trials.JAMA 2005;293:1754–1765.
  • [38]Topol EJ;GUSTO Investigators.Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycolprotein IIb/IIIa inhibition:the GUSTO V randomized trial.Lancet 2001;357:1905–1914.
  • [39]Collins R,Mac Mahan S,Flather M,et al.Clinical effects of anticoagulant therapy in suspected acute myocardial infarction:systematic overview of randomyzed trials.BMJ 1996;313:652–659.
  • [40]Antmam EM,Morrow DA,MCCabe CH,et al.Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST elevation myocardial infarction.Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction treatment thrombolysis in myocardial infarction study (EXTRACT-TIMI 25).Am Heart J 2005;149:217–226.
  • [41]Krumholz HM,Radford MJ,Wang Y,et al.National use and effectiveness of beta-blockerss for the treatment of elderly patients after acute myocardial infarction:National Cooperative Cardiovascular Project.JAMA 1998;280:623-629.
  • [42]Hjalmarson A,Elmfeldt D,Herlitz J,et al.Effect on mortality of metropolol in acute myocardial infarction:a double–blind randomized trial.Lancet 1981;11:823–827.
  • [43]First International Study of Infarct Collaborative Group.Randomized Trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction:ISIS-1.Lancet 1986;11:57–66.
  • [44]Krumholz HM,Radford MJ,Wang Y,et al.Early betablocker therapy for acute myocardial infarction in elderly patients.Ann Intern Med 1999;131:648–654.
  • [45]Gravina CF,Rosa RF,Franken RA,et al.Sociedade Brasileira de Cardiologia.II Diretrizes Brasileiras em Cardiogeriatria.Arq Bras Cardiol 2010;95 (3 Suppl 2):S1–S112.
  • [46]GISSI-3:effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction.Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.Lancet 1994;343:1115–1122.
  • [47]ISIS-4 Collaborative Group.ISIS-4:A Randomized factorial trial assessing early oral captopril,oral mononitrate and intravenous magnesium sulphatein 58050 patients with suspected acute myocardial infarction.Lancet 1995;345:669–685.
  • [48]ACE Inhibitor Myocardial Infarction Collaborative Group.Indications for ACE inhibitors in the early treatment of acute myocardial infarction systematic overview of individual data from 100000 patients in randomized trials.Circulation 1998:97:2202–2212.
  • [49]Krumholz HM,Chen YT,Wang Y,et al.Aspirin and angiotensin converting enzyme inhibitors among elderly survivors hospitalization for an acute myocardial infarction.Arch Intern Med 2001;161:538–544.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn